Schedule 13G ownership disclosure

AVADEL PHARMACEUTICALS PLC

Security class unavailable · CUSIP: 05337M104

Event date: 2022-05-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,906,665
Percent of class
4.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-22-007812
Form type
SC 13G
Filer
AVADEL PHARMACEUTICALS PLC
CIK
CIK 1012477
Filed
Jun 03, 2022
Reporting period
May 27, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub